abrdn Life Sciences Investors
Research abrdn Life Sciences Investors (HQL) on Bullrun: dividend yield 13.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHQL
- ExchangeNYSE
- CountryUnited States
- SectorFinancial Services
- IndustryAsset Management
- CurrencyUSD
- Dividend yield13.0%
- Financial periodQ1 2026
Valuation Snapshot
dividend yield is 13.0%.
Peer valuation comparison
Latest dividend yield is 12.98% versus a Financial Services sector median of 3.66% (255.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 86.39M | USD 85.59M | USD 31.71M | n/a | 2.79 | USD 75.54K | n/a | USD 513.66M |
| FY2024 | USD 86.69M | USD 85.30M | n/a | n/a | 3.04 | USD 1 | n/a | USD 459.69M |
| FY2023 | USD 23.52M | USD 22.35M | n/a | n/a | 0.79 | USD 477 | n/a | USD 401.93M |
| FY2022 | -USD 103.25M | -USD 104.60M | n/a | n/a | -1.73 | USD 445 | n/a | USD 397.90M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | n/a | n/a | 12.4% | 2.24 |
| 2025 | 2025-12-31 | n/a | n/a | 10.8% | 1.82 |
| 2024 | 2024-12-31 | n/a | n/a | 14.2% | 1.86 |
| 2023 | 2023-12-29 | n/a | n/a | 9.4% | 1.27 |
| 2022 | 2022-12-30 | n/a | n/a | 9.6% | 1.36 |
| 2021 | 2021-12-31 | n/a | n/a | 8.8% | 1.69 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.24 USD, yield 13.0%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.82 USD |
| FY2024 | 1.86 USD |
| FY2023 | 1.27 USD |
| FY2022 | 1.36 USD |
About abrdn Life Sciences Investors
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.
Related stock research
Other Financial Services stocks
Frequently asked questions
Does abrdn Life Sciences Investors pay a dividend?
abrdn Life Sciences Investors has a dividend yield of 13.0%.
What does abrdn Life Sciences Investors do?
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies.